Emilie Besnard BioAge Labs
8 protocols

Emily Cope Northern Arizona University
11 protocols

Francesca Mingozzi University of Milano-Bicocca
2 protocols

Ivan Zanoni Harvard Medical School
76 protocols

Reviewer
Emilie Battivelli
  • Post-Doc, Buck institute
Research focus
  • Molecular biology
  • 1 Author merit

Education

PhD, Paris VII- Denis Diderot, France, 2012

Current position

Postdoctoral Fellow, Verdin Laboratory, Buck Institute For Research on Aging, USA

Publications

  1. https://scholar.google.com/citations?user=MVk8xQcAAAAJ&hl=en
1 Protocol published
HIVGKO: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4+ T Cells
Authors:  Emilie Battivelli and Eric Verdin, date: 10/20/2018, view: 486, Q&A: 0
While able to suppress HIV replication in HIV infected individuals, combination antiretroviral therapy (ART) fails to eliminate viral latent reservoir, which consists in integrated transcriptional silenced HIV provirus. So far, identification of ...
5 Protocols reviewed
Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction
Authors:  Georgios Pissas and Theodoros Eleftheriadis, date: 01/20/2019, view: 48, Q&A: 0
Humoral alloimmunity remains a significant and unresolved problem that constrains allograft survival. Thus, there is a need for the development of an easy, preferably non-radioactive, and inexpensive protocol for assessing the effect of various drug ...
More >
Flow Cytometric Analysis of HIV-1 Transcriptional Activity in Response to shRNA Knockdown in A2 and A72 J-Lat Cell Lines
Authors:  Daniela Boehm and Melanie Ott, date: 06/05/2017, view: 3485, Q&A: 0
The main obstacle to eradicating HIV-1 from patients is post-integration latency (Finzi et al., 1999). Antiretroviral treatments target only actively replicating virus, while latent infections that have low or no transcriptional activity ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.